197. Evaluation of Risk Factors and Outcomes Associated with Daptomycin-nonsusceptible Staphylococcus aureus Bacteremia

BACKGROUND: Staphylococcus aureus (SA) is a major cause of hospital-associated infections in the US with high morbidity and mortality. With SA developing resistance to many first-line antibiotics, daptomycin (DAP) has become a critical agent for SA therapy. However, increasing use of DAP has resulte...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanna, Zachary W, Alangaden, George J, Zervos, Marcus, Suleyman, Geehan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678010/
http://dx.doi.org/10.1093/ofid/ofad500.270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678010/
http://dx.doi.org/10.1093/ofid/ofad500.270

Ejemplares similares